Pricing Log in Create free account

Arvinas, Inc. (ARVN) vs PureTech Health PLC Sponsored ADR (PRTCY)

Arvinas, Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. Arvinas, Inc. and PureTech Health PLC Sponsored ADR are of similar size ($428.9M and $424.0M). PureTech Health PLC Sponsored ADR grew revenue faster over the last twelve months: 28.5% against −11.9%. Arvinas, Inc. has the higher net margin (−3.45% vs −199.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, PureTech Health PLC Sponsored ADR leads on 11 and Arvinas, Inc. on 5.

Valuation

Metric ARVN PRTCY Biotechnology median
P/E n/m n/m 10.60
P/S 1.52 n/m 9.40
P/B 0.81 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 4.29 0.81 0.66
EV/Sales (0.51) (9.10) 9.02
Earnings yield (2.39%) (1.32%) (32.88%)
Free cash flow yield (38.24%) 0.00% (23.13%)

Profitability

Metric ARVN PRTCY Biotechnology median
Gross margin 96.69% 0.00% 68.51%
Operating margin (12.13%) 0.00% 0.00%
Net margin (3.45%) (199.36%) 0.00%
Free cash flow margin (58.05%) 0.00% 0.00%
Return on equity (1.76%) 0.00% (51.96%)
Return on assets (1.31%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARVN PRTCY Biotechnology median
Revenue growth (TTM) (11.85%) 28.48% 6.76%
EPS growth (last fiscal year) 58.84% (318.75%) 29.88%
Revenue growth, 5-year CAGR 58.93% (16.92%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARVN PRTCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.39 6.59 4.97
Net debt to EBITDA 5.62 3.03 1.01

Dividend

Metric ARVN PRTCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARVN PRTCY Biotechnology median
Market cap 428.93m 424.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack